We are live on ! Find out more
E

Ergoteles Portfolio holdings

AUM $68.2M
1-Year Est. Return 36.16%
This Fund
S&P 500
This Quarter Est. Return
+3.98%
1 Year Est. Return
+36.16%
3 Year Est. Return
+76.43%
5 Year Est. Return
10 Year Est. Return
AUM
$2.56B
AUM Growth
-$165M
Cap. Flow
-$121M
Cap. Flow %
-4.75%
Top 10 Hldgs %
16.93%
Holding
2,032
New
633
Increased
247
Reduced
287
Closed
843

Top Buys

Rank Stock Value
1
CINF icon
Cincinnati Financial
CINF
+$48.5M
2
FICO icon
Fair Isaac
FICO
+$44.6M
3
STT icon
State Street
STT
+$44.5M
4
CMI icon
Cummins
CMI
+$43.2M
5
PRU icon
Prudential Financial
PRU
+$42.9M

Sector Composition

Rank Sector Weight
1 Financials 24.3%
2 Industrials 11.34%
3 Technology 11.26%
4 Healthcare 10.88%
5 Consumer Discretionary 8.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CHR icon
1151
Cheer Holding
CHR
$3.54M
$25.3K ﹤0.01%
23
-175
-88% -$257K
BODI icon
1152
The Beachbody Company
BODI
$79.1M
$23.8K ﹤0.01%
+987
New +$30.6K
SKIL icon
1153
Skillsoft
SKIL
$58.9M
$23.6K ﹤0.01%
+590
New +$21.1K
FTH
1154
Faeth Therapeutics
FTH
$754M
$23.3K ﹤0.01%
776
-941
-55% -$27.9K
DCFC
1155
DELISTED
Tritium DCFC Limited Ordinary Shares
DCFC
$23K ﹤0.01%
+90
New +$26.4K
OMIC
1156
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
$22.6K ﹤0.01%
623
-1,640
-72% -$100K
SDC
1157
DELISTED
SmileDirectClub, Inc. Class A Common Stock
SDC
$21.5K ﹤0.01%
50,043
-237,380
-83% -$122K
SMMT icon
1158
Summit Therapeutics
SMMT
$10.5B
$21.4K ﹤0.01%
+12,234
New +$33.4K
PIII icon
1159
P3 Health Partners
PIII
$34.9M
$20.4K ﹤0.01%
+385
New +$23.1K
VHC icon
1160
VirnetX Holding Corp
VHC
$51M
$18.9K ﹤0.01%
720
-8,919
-93% -$289K
NNBR icon
1161
NN Inc
NNBR
$273M
$18.1K ﹤0.01%
16,889
-58,971
-78% -$105K
RPID icon
1162
Rapid Micro Biosystems
RPID
$100M
$17.8K ﹤0.01%
13,624
-16,950
-55% -$22K
CADL icon
1163
Candel Therapeutics
CADL
$730M
$15.6K ﹤0.01%
11,416
-14,698
-56% -$28.7K
PRSO icon
1164
Peraso
PRSO
$10.5M
$13.5K ﹤0.01%
+620
New +$19.3K
AUVI
1165
DELISTED
Applied UV, Inc. Common Stock
AUVI
$12.8K ﹤0.01%
+116
New +$15.4K
TRVN
1166
DELISTED
Trevena, Inc.
TRVN
$12.5K ﹤0.01%
+713
New +$23.2K
TAOX
1167
Tao Synergies Inc
TAOX
$25.9M
$11.9K ﹤0.01%
+595
New +$15.7K
UTRS
1168
DELISTED
Minerva Surgical, Inc. Common Stock
UTRS
$11.9K ﹤0.01%
2,704
+2,052
+315% +$12.6K
AWH
1169
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
$11.3K ﹤0.01%
2,058
-6,940
-77% -$47.1K
LSF icon
1170
Laird Superfood
LSF
$47.3M
$11.3K ﹤0.01%
+13,920
New +$14.6K
CS
1171
DELISTED
Credit Suisse Group
CS
$11.1K ﹤0.01%
+12,434
New +$34.7K
GYRE icon
1172
Gyre Therapeutics
GYRE
$683M
$10.4K ﹤0.01%
+3,354
New +$12.7K
KAVL
1173
DELISTED
Kaival Brands Innovations Group
KAVL
$10.1K ﹤0.01%
+671
New +$10.8K
NCMI icon
1174
National CineMedia
NCMI
$362M
$9.81K ﹤0.01%
+7,430
New +$17.3K
ROI
1175
DELISTED
RiskOn International, Inc. Common Stock
ROI
$9.67K ﹤0.01%
+2,751
New +$20.4K

Similar funds

Ergoteles's Q1 2023 Portfolio in Review

As of Q1 2023, Ergoteles held 2,032 positions worth $2.56B, down 6.1% from $2.72B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Ergoteles withdrew a net $121M in Q1 2023, closing 843 positions and reducing 287 holdings. Its most notable exit was STORE Capital Corporation, an estimated $46.2M position sold in full.

By sector, the portfolio is most concentrated in Financials at 24% of assets, up from 15% a quarter earlier, followed by Industrials and Technology.

Against the trend, Ergoteles opened a new position in Cincinnati Financial worth $47.8M.

  • Ergoteles's largest Q1 2023 buy was Cincinnati Financial: 426,553 shares worth $47.8M.
  • Ergoteles added most to Fair Isaac in Q1 2023, an estimated $44.6M increase.
  • Ergoteles's biggest Q1 2023 reduction was Steel Dynamics, cutting an estimated $60.9M.
  • Ergoteles fully exited STORE Capital Corporation in Q1 2023, selling an estimated $46.2M.
  • Ergoteles's ten largest holdings make up 17% of its $2.56B portfolio in Q1 2023.
  • Ergoteles opened 633 new positions and closed 843 in Q1 2023.
  • Ergoteles's portfolio value fell 6.1% quarter-over-quarter to $2.56B.

Based on Ergoteles's 13F filing for Q1 2023, filed 10 May 2023.